Grifols | GRFS - Acreedores Comerciales

Precio De Mercado
7.71
Cambio Diario
0.13 1.72%
Mensual
-14.99%
Anual
-0.52%
Q1 Expectativa
7.36




Acreedores Comerciales Cambio Fecha
Alaunos Therapeutics USD 843K 34K 2025-09
Arca Biopharma USD 4.16M 1.95M 2025-12
aTyr Pharma USD 55.07M 51.01M 2025-12
Bio Path USD 4.9M 1.42M 2025-09
Brainstorm Cell Therapeutics USD 6.42M 423K 2025-09
Capricor Therapeutics 1.65M 1.06M 2025-12
Cara Therapeutics USD 2.42M 2.42M 2025-06
Esperion Therapeutics USD 65.07M 12.44M 2025-12
GlaxoSmithKline GBP 15.38B 294M 2025-12
Grifols EUR 987.75M 47.87M 2025-12
Immunic USD 7.92M 25K 2025-09
Infinity Pharmaceuticals USD 1.5M 433K 2023-06
Minerva Neurosciences USD 640K 305K 2025-12
Nektar Therapeutics USD 15.56M 1.28M 2025-09
Sangamo BioSciences USD 10.74M 7.46M 2025-06
TherapeuticsMD USD 143K 4K 2024-06